文献速递产科母胎医学

母胎医学会咨询系列第65号:经腹宫颈环扎术

Society for Maternal-Fetal Medicine Consult Series #65: Transabdominal cerclage.
PubMed 文献 · Am J Obstet Gynecol · 2023-02-28

经腹宫颈环扎术可能优于经阴道环扎术,但并发症更多且需剖宫产分娩。本咨询回顾经腹宫颈环扎术利弊的现有文献并给出8条推荐,涵盖适应证、术式选择、孕期时机、宫颈长度筛查、补充孕酮、妊娠丢失处理及分娩时机。

要点

  • 既往经阴道环扎(病史或超声指征)后28周前 spontaneous 单胎分娩者,推荐提供经腹环扎(GRADE 1B)。
  • 腹腔镜与开腹经腹环扎均可接受,术式选择取决于孕周、技术可行性、资源和专长(GRADE 2B)。
  • 经腹环扎者不推荐常规经阴道宫颈长度筛查(GRADE 1C);建议37 0/7至39 0/7周剖宫产(GRADE 2C)。

核心结论

  • 经腹宫颈环扎术可用于特定宫颈机能不全患者,但需权衡并发症增加和剖宫产分娩的需求。

研究设计与样本

  • 母胎医学会(Society for Maternal-Fetal Medicine)发布的咨询系列,基于现有文献综述制定推荐。

主要发现

  • 经腹环扎术相比经阴道环扎术可能具有优势,但与发病率增加和需剖宫产分娩相关。

关键数值与推荐

  • 推荐对既往经阴道环扎(病史或超声指征)且随后在28周前 spontaneous 单胎分娩者提供经腹环扎(GRADE 1B)。
  • 推荐对可能适合或已行经腹环扎者进行母胎医学咨询(最佳实践)。
  • 建议腹腔镜与开腹经腹环扎均可接受,术式选择取决于孕周、技术可行性、可用资源和专长(GRADE 2B)。
  • 建议经腹环扎可在孕前或早孕期进行,胎儿结局相似;若指征患者就诊时已过早孕期,22周前仍可考虑(GRADE 2C)。
  • 推荐对经腹环扎在位者不进行常规经阴道宫颈长度筛查(GRADE 1C);建议对复发 spontaneous 早产风险者(包括经腹环扎在位者)讨论补充阴道孕酮并共同决策(GRADE 2C)。

临床怎么用

  • 对符合指征者提供经腹环扎,并转诊母胎医学咨询。
  • 经腹环扎术式可选腹腔镜或开腹,依据孕周、技术、资源和专长决定。
  • 经腹环扎可在孕前或早孕期放置,过时者22周前仍可考虑。
  • 经腹环扎在位者不常规筛查宫颈长度;讨论补充阴道孕酮并共同决策。
  • 妊娠丢失时根据孕周和资源选择手术或拆除环扎后处理;建议37 0/7至39 0/7周剖宫产。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cerclage is the mainstay of treatment for cervical insufficiency. Although transabdominal cerclage may have advantages over transvaginal cerclage, it is associated with increased morbidity and the need for cesarean delivery. In this Consult, we review the current literature on the benefits and risks of transabdominal cerclage and provide recommendations based on the available evidence. The following are Society for Maternal-Fetal Medicine recommendations: (1) we recommend that transabdominal cerclage placement be offered to patients with a previous transvaginal cerclage placement (history or ultrasound indicated) and subsequent spontaneous singleton delivery before 28 weeks of gestation (GRADE 1B); (2) we recommend maternal-fetal medicine consultation for counseling patients who may be candidates for transabdominal cerclage and those who have undergone transabdominal cerclage (Best Practice); (3) we suggest that both laparoscopic transabdominal cerclage and open transabdominal cerclage are acceptable and the decision of approach may depend on gestational age, technical feasibility, available resources, and expertise (GRADE 2B); (4) we suggest that transabdominal cerclage can be performed before pregnancy or in the first trimester of pregnancy with similar fetal outcomes. If a patient with an indication for transabdominal cerclage presents after the first trimester of pregnancy, transabdominal cerclage can still be considered before 22 weeks of gestation (GRADE 2C); (5) we recommend that routine transvaginal cervical length screening not be performed for patients with a transabdominal cerclage in situ (GRADE 1C); (6) we suggest that for individuals at risk of recurrent spontaneous preterm birth, including those with a transabdominal cerclage in situ, a risk-benefit discussion of supplemental vaginal progesterone be undertaken with shared decision-making (GRADE 2C); (7) we suggest that pregnancy loss be managed with dilation and curettage or dilation and evacuation with a transabdominal cerclage in situ or via usual obstetrical management after laparoscopic removal of the transabdominal cerclage, depending on gestational age and resources available (GRADE 2C); and (8) we suggest cesarean delivery between 37 0/7 and 39 0/7 weeks of gestation for patients with a transabdominal cerclage in situ (GRADE 2C).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Temming L, Mikhail E. Society for Maternal-Fetal Medicine Consult Series #65: Transabdominal cerclage. Am J Obstet Gynecol. 2023. PMID: 36858095. doi:10.1016/j.ajog.2023.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。